Application
19168641 · CD40L-SPECIFIC TN3-DERIVED SCAFFOLDS FOR THE TREATMENT AND PREVENTION OF SJOGREN'S SYNDROME
Filed 2025-09-24 · Pending The official file ↗ · Art unit 1643 · CPC C07K 16/2875 · Viela Bio, Inc. · AMGEN INC.
Office actions
0
first was
RCEs
0
no appeal
To first action
n/a
to disposition n/a
Statutes raised
·
0 actions read